UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 391

Sortiert nach

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Journal of Clinical Microbiology, 2012-09, Vol.50 (9), p.2846-2856

2012

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Clinical Microbiology Reviews, 2007-01, Vol.20 (1), p.133-163

2007

Link zum Volltext

Verfügbarkeit prüfen

Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus

Journal of clinical microbiology, 2004-10, Vol.42 (10), p.4419-4431

2004

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2497-2506

2010

Link zum Volltext

Verfügbarkeit prüfen

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

Journal of Clinical Microbiology, 2010-04, Vol.48 (4), p.1366-1377

2010

Link zum Volltext

Verfügbarkeit prüfen

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Journal of Clinical Microbiology, 2010-09, Vol.48 (9), p.3251-3257

2010

Link zum Volltext

Verfügbarkeit prüfen

Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing

Clinical Microbiology Reviews, 2006-04, Vol.19 (2), p.435-447

2006

Link zum Volltext

Verfügbarkeit prüfen

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

Journal of Clinical Microbiology, 2008-08, Vol.46 (8), p.2620-2629

2008

Link zum Volltext

Verfügbarkeit prüfen

Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999

Clinical infectious diseases, 2001-05, Vol.32 (Supplement-2), p.S114-S132

2001

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

Journal of Clinical Microbiology, 2008-01, Vol.46 (1), p.150-156

2008

Link zum Volltext

Verfügbarkeit prüfen

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp

Journal of Clinical Microbiology, 2010-01, Vol.48 (1), p.52-56

2010

Link zum Volltext

Verfügbarkeit prüfen

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Journal of Clinical Microbiology, 2006-03, Vol.44 (3), p.819-826

2006

Link zum Volltext

Verfügbarkeit prüfen

Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi

Journal of Clinical Microbiology, 2003-08, Vol.41 (8), p.3623-3626

2003

Link zum Volltext

Verfügbarkeit prüfen

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

Journal of Clinical Microbiology, 2009-01, Vol.47 (1), p.117-123

2009

Link zum Volltext

Verfügbarkeit prüfen

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

Journal of Clinical Microbiology, 2012-06, Vol.50 (6), p.2040-2046

2012

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

Journal of Clinical Microbiology, 2006-03, Vol.44 (3), p.760-763

2006

Link zum Volltext

Verfügbarkeit prüfen

Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens

Journal of Clinical Microbiology, 2009-12, Vol.47 (12), p.3797-3804

2009

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model

Antimicrobial Agents and Chemotherapy, 2008-10, Vol.52 (10), p.3497-3503

2008

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods

Journal of Clinical Microbiology, 2009-10, Vol.47 (10), p.3170-3177

2009

Link zum Volltext

Verfügbarkeit prüfen

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

Journal of Clinical Microbiology, 2009-10, Vol.47 (10), p.3185-3190

2009

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

Journal of Clinical Microbiology, 2009-10, Vol.47 (10), p.3323-3325

2009

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Pharmacodynamic Characterization of Anidulafungin in a Neutropenic Murine Candidiasis Model

Antimicrobial Agents and Chemotherapy, 2008-02, Vol.52 (2), p.539-550

2008

Link zum Volltext

Verfügbarkeit prüfen

Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species

Journal of Clinical Microbiology, 2010-05, Vol.48 (5), p.1592-1599

2010

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activities of Anidulafungin against More than 2,500 Clinical Isolates of Candida spp., Including 315 Isolates Resistant to Fluconazole

Journal of Clinical Microbiology, 2005-11, Vol.43 (11), p.5425-5427

2005

Link zum Volltext

Verfügbarkeit prüfen

Role of sentinel surveillance of candidemia: Trends in species distribution and antifungal susceptibility

Journal of clinical microbiology, 2002-10, Vol.40 (10), p.3551-3557

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 391

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(390)
Mit Volltextzugriff
(363)

Publikationsform

Sprache

Englisch
(391)
Japanisch
(64)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(360)
Life Sciences & Biomedicine
(356)
Humans
(327)
Microbiology
(296)
Biological And Medical Sciences
(143)
Infectious Diseases
(117)
Medical Sciences
(112)
Mycology
(103)
Antifungal Agents - Pharmacology
(96)
Microbial Sensitivity Tests
(85)
Male
(81)
Candida - Drug Effects
(78)
Epidemiology
(78)
Female
(77)
Fundamental And Applied Biological Sciences. Psychology
(74)
Bacteriology
(69)
Miscellaneous
(60)
Adult
(59)
Candida
(56)
Candidiasis - Microbiology
(53)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus

In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens

In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model

In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

In Vivo Pharmacodynamic Characterization of Anidulafungin in a Neutropenic Murine Candidiasis Model

Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species

In Vitro Activities of Anidulafungin against More than 2,500 Clinical Isolates of Candida spp., Including 315 Isolates Resistant to Fluconazole

Role of sentinel surveillance of candidemia: Trends in species distribution and antifungal susceptibility

Suchergebnisse filtern